FRUSEMIDE PHARMACOKINETICS IN PATIENTS WITH LIVER-DISEASE

被引：36

作者：

ALLGULANDER, C

BEERMANN, B

SJOGREN, A

机构：

[1] SERAFIMER HOSP,DEPT MED,S-11283 STOCKHOLM,SWEDEN

[2] SERAFIMER HOSP,CLIN PHARMACOL LAB,S-11283 STOCKHOLM,SWEDEN

来源：

CLINICAL PHARMACOKINETICS | 1980年 / 5卷 / 06期

关键词：

D O I：

10.2165/00003088-198005060-00005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：570 / 575

页数：6

共 11 条

[1]

ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49

[2] DISTRIBUTION, ELIMINATION AND EFFECT OF FUROSEMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH HEART-FAILURE [J].

ANDREASEN, F ;

MIKKELSEN, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) :15-22

[3]

BEERMANN B, 1977, CLIN PHARMACOL THER, V22, P70

[4] FATE OF FUROSEMIDE IN MAN [J].

BEERMANN, B ;

DALEN, E ;

LINDSTROM, B ;

ROSEN, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (01) :57-61

[5]

BEERMANN B, 1980, CLIN PHARMACOKINET, V5, P221, DOI 10.2165/00003088-198005030-00003

[6] PROTEIN-BINDING AND KINETICS OF DRUGS IN LIVER-DISEASES [J].

BLASCHKE, TF .

CLINICAL PHARMACOKINETICS, 1977, 2 (01) :32-44

[7] BINDING OF AMOBARBITAL, PENTOBARBITAL AND DIPHENYLHYDANTOIN TO BLOOD-CELLS AND PLASMA-PROTEINS IN HEALTHY VOLUNTEERS AND UREMIC PATIENTS [J].

EHRNEBO, M ;

ODARCEDERLOF, I .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (06) :445-453

[8] GAS-CHROMATOGRAPHIC DETERMINATION OF FUROSEMIDE IN PLASMA USING AN EXTRACTIVE ALKYLATION TECHNIQUE AND AN ELECTRON-CAPTURE DETECTOR [J].

LINDSTROEM, B ;

MOLANDER, M .

JOURNAL OF CHROMATOGRAPHY, 1974, 101 (01) :219-221

[9] DRUG-METABOLISM IN PRODUCTION OF LIVER-INJURY [J].

MITCHELL, JR ;

POTTER, WZ .

MEDICAL CLINICS OF NORTH AMERICA, 1975, 59 (04) :877-885

[10]

RANE A, 1978, CLIN PHARMACOL THER, V24, P199

← 1 2 →